Narendra Agrawal

13PUBLICATIONS
23CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursTraditional Chinese medicine and treatmentsRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 09, 2026
Acalabrutinib Added To Rituximab, Bendamustine (ABR) in Newly Diagnosed High Risk Mantle Cell Lymphoma: an Early Indian Experience.

|Jun 23, 2026
Is it Necessary to Achieve a Very Good Partial Response Prior to Transplant? Comparison of Outcomes in Pre-Transplant Partial Response Versus Very Good Partial Response or Deeper.

|Mar 04, 2025
Evaluating Health-Related Quality of Life in Thalassemia: Low-Dose Thalidomide vs. Standard Care-Insights from a Comparative Study.

Varsha Mishra, Pratibha Singh Yadav, Reema Singh

|Sep 16, 2024
Impact of the COVID-19 pandemic on treatment of patients with acute myeloid leukaemia in India.

Chepsy Philip, Sushil Selvarajan, Lingaraj Nayak

|Jul 05, 2022
Busulfan and cyclophosphamide-based conditioning regimen still holds the promise of being a safe and efficacious regimen for allogeneic transplantation in patients with transfusion-dependent thalassemia, even in high risk.

Pallavi Mehta, Jyotsna Kapoor, Aakanksha Singh

|Jul 26, 2021
Outcomes of COVID-19 in Hematopoietic Stem Cell Transplant Recipients: Multicenter Retrospective Analysis.

Narendra Agrawal, Reema Singh, Sanjeev Kumar Sharma

Pageof 3

Frequent Collaborators

5 joint publications

Dinesh Bhurani

4 joint publications

Reema Singh

3 joint publications

Jyotsna Kapoor

2 joint publications

Prasanth Ganesan